ARIANNE PHOSPHATE INC (DAN.CA) Stock Fundamental Analysis

Name: ARIANNE PHOSPHATE INC (DAN) Stock
Brand: ARIANNE PHOSPHATE INC
Rating: 6 (3 reviews)

Canada - TSX Venture Exchange - TSX-V:DAN - CA04035D1024 - Common Stock

0.29 CAD

+0.02 (+7.41%)

Last: 1/28/2026, 7:00:00 PM

Fundamental Rating

Overall DAN gets a fundamental rating of 0 out of 10. We evaluated DAN against 820 industry peers in the Metals & Mining industry. Both the profitability and financial health of DAN have multiple concerns. DAN has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DAN has reported negative net income.
In the past year DAN has reported a negative cash flow from operations.
In the past 5 years DAN always reported negative net income.
DAN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of DAN (-20.47%) is comparable to the rest of the industry.
DAN has a Return On Equity of -67.29%. This is comparable to the rest of the industry: DAN outperforms 41.59% of its industry peers.

		Industry Rank	Sector Rank
ROA	-20.47%
ROE	-67.29%
ROIC	N/A

ROA(3y)-10.29%

ROA(5y)-10.6%

ROE(3y)-21.53%

ROE(5y)-21.77%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DAN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DAN has more shares outstanding
DAN has a worse debt/assets ratio than last year.

2.2 Solvency

DAN has an Altman-Z score of -1.97. This is a bad value and indicates that DAN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DAN (-1.97) is worse than 63.54% of its industry peers.
DAN has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.22, DAN is doing worse than 66.95% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Altman-Z	-1.97

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

DAN has a Current Ratio of 0.07. This is a bad value and indicates that DAN is not financially healthy enough and could expect problems in meeting its short term obligations.
DAN's Current ratio of 0.07 is on the low side compared to the rest of the industry. DAN is outperformed by 82.07% of its industry peers.
DAN has a Quick Ratio of 0.07. This is a bad value and indicates that DAN is not financially healthy enough and could expect problems in meeting its short term obligations.
DAN's Quick ratio of 0.07 is on the low side compared to the rest of the industry. DAN is outperformed by 81.83% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.07
Quick Ratio	0.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for DAN have decreased strongly by -184.62% in the last year.

EPS 1Y (TTM)-184.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-94%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.